6-methyl-5-propan-2-yl-3,4-dihydro-2H-pyran

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 氧杂环化合物
• 英文名称: 6-methyl-5-propan-2-yl-3,4-dihydro-2H-pyran
• 化学式: C₉H₁₆O
• 分子量: 140.22
• InChiKey: QJNXVZGRSCPKPV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• Histone methyltransferase inhibitors
  申请人：GLOBAL BLOOD THERAPEUTICS, INC.

  公开号：US10829452B2

  公开（公告）日：2020-11-10

  The present disclosure provides compounds of Formula (I) that are histone methyltransferases G9a and/or GLP inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of G9a and/or GLP such as cancers and hemoglobinpathies (e.g., beta thalassemia and sickle cell disease). Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds. where R1, alk, R2, Z1, Z2, X, R3, R4, B, a, and b are as described herein.

  本公开提供的式(I)化合物是组蛋白甲基转移酶G9a和/或GLP抑制剂，因此可用于治疗可通过抑制G9a和/或GLP治疗的疾病，如癌症和血红蛋白病（如β地中海贫血和镰状细胞病）。此外，还提供了含有此类化合物的药物组合物和制备此类化合物的工艺。 其中 R1、alk、R2、Z1、Z2、X、R3、R4、B、a 和 b 如本文所述。
• 4, 5-RING ANNULATED INDOLE DERIVATIVES FOR TREATING OR PREVENTING OF HCV AND RELATED VIRAL INFECTIONS
  申请人：Anilkumar Gopinadhan N.

  公开号：US20100196319A1

  公开（公告）日：2010-08-05

  The present invention relates to 4,5-ring annulated indole derivatives of formula (I), compositions comprising at least one 4,5-ring annulated indole derivatives, and methods of using the 4,5-ring annulated indole derivatives for treating or preventing a viral infection or a virus-related disorder in a patient, wherein ring Z of formula (I), is cyclohexyl, cyclohexenyl, 6-membered heterocycloalkyl, 6-membered heterocycloalkenyl, 6-membered aryl or 6-membered heteroaryl, wherein R 1 , R 2 , R 3 , R 6 , R 7 and R 10 are as described herein.
• US8415387B2
  申请人：——

  公开号：US8415387B2

  公开（公告）日：2013-04-09
• [EN] 4, 5-RING ANNULATED INDOLE DERIVATIVES FOR TREATING OR PREVENTING OF HCV AND RELATED VIRAL INFECTIONS<br/>[FR] DÉRIVÉS CONDENSÉS À 4,5 NOYAUX DESTINÉS AU TRAITEMENT OU À LA PRÉVENTION DU VHC ET DES INFECTIONS VIRALES ASSOCIÉES
  申请人：SCHERING CORP

  公开号：WO2008082488A1

  公开（公告）日：2008-07-10

  [EN] The present invention relates to 4, 5 - ring annulated indole derivatives of formula ( I ), compositions comprising at leas t one 4, 5 - ring annulated indole derivatives, and methods of using the 4, 5 - ring annulated ^ndole derivatives for treating or preventing a viral inf ection or a virus - related disorder in a patient, (I) wherein ring Z of formula (I), is cyclohexyl, cyclohexenyl, 6-membered heterocycloalkyl, 6- membered heterocycloalkenyl, 6-membered aryl or 6-membered heteroaryl, wherein R¹, R², R³, R⁶. R⁷ and R¹⁰ are as described herein.
  [FR] L'invention concerne des dérivés indole condensés à 4,5 noyaux de la formule (I), des compositions renfermant au moins un dérivé indole condensé à 4,5 noyaux, et des procédés d'utilisation des dérivés indole condensés à 4,5 noyaux dans le traitement ou la prévention d'une infection virale ou d'un trouble lié à un virus chez un patient, (I) le cycle Z de la formule (I) étant cyclohexyle, cyclohexényle, hétérocycloalkyle à 6 chaînons, hétérocycloalcényle à 6 chaînons, aryle à 6 chaînons ou hétéroaryle à 6 chaînons, où R¹, R², R³, R⁶, R⁷ et R¹⁰ sont tels que définis dans la description.